Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 2 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
48 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Avante Biocapital Advisers from Brussel, company number BE1015606925, closed financial year 2025 with a result of € -1.1 million after tax. For that financial year Avante Biocapital Advisers recorded a gross margin of € -1.1 million and equity of € -2.7 million. Compared with financial year 2024, the result moved from € -1.6 million to € -1.1 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 12, 2026.
€ -2.7 million
▼ € 1.1 million vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1.1 million
▲ 32 % less loss than in 2024
Profit after tax over the fiscal year.
€ 199,847
▼ 64% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -2.7 million.
Debts at end 2025
€ 2.7 million
▲ 8% vs 2024
Loans from banks and other lenders, long and short.
€ 451,271
▲ 19% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 9,523
▼ 52% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € -1,619,333 | € -1,090,859 | ▲ € 528,474 |
| Profit after taxes | € -1,620,197 | € -1,103,445 | ▲ € 516,752 |
| Equity | € -1,620,197 | € -2,723,641 | ▼ € 1.1 million |
| Total debts | € 2,877,498 | € 3,139,188 | ▲ 9% |
| Cash | € 549,648 | € 199,847 | ▼ 64% |
| Retained profit | € -1,620,197 | € -2,723,641 | ▼ € 1.1 million |
| Bank debt | € 2,478,394 | € 2,678,394 | ▲ 8% |
| Balance sheet total | € 1,257,302 | € 415,547 | ▼ 67% |
Key figures of Avante Biocapital Advisers, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Avante Biocapital Advisers?
What happened at Avante Biocapital Advisers in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 1.1 million. Source: NBB ↗
- New establishment in Brussel. KBO
- Matthew James Foy became a director. NBB
- Mette Kirstine Agger became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 1.6 million loss in 2024 to € 1.1 million loss in 2025.
A new publication or filing at Avante Biocapital Advisers? We notify you, reason included.
Follow Avante Biocapital AdvisersDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Avante Biocapital Advisers are Matthew James Foy and Mette Kirstine Agger.
Directors
According to the 2025 annual accounts
Matthew James Foy
Director
since 2024
Mette Kirstine Agger
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Oude Graanmarkt 63
1000 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 48 companies are registered at this address.
All companies at this address →Moeve Chemicals Belgium
€ 1.3 million gross margin · 2025
BIOTECH FONDS VLAANDEREN
Fietsersbond
€ 686,591 gross margin · 2025
Participatiemaatschappij Vlaanderen
€ 16.8 million revenue · 2025
SUSTAINABLE ENERGY VENTURES
+43 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1015.606.925
- VAT number
- BE 1015.606.925
- Registered office
- Oude Graanmarkt 63, 1000 Brussel
- Names & denominations
- Avante Biocapital Advisers
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 October 2024
- Peppol
- Active · Active since 13 Jan 2026
- Activities · NACE
Overige zakelijke dienstverlening, neg